Search results
PROMOTED
Start date:
Jan 21, 2026
Pacemaker implantation remains one of the most common complications after TAVI. In this webinar, chaired by Prof Rafal Dworakowski (Abbott APAC Medical Affairs Director, Singapore, SG) and Dr Simon Lam (Queen Mary Hospital, Hong Kong, HK), leading specialists will focus on the anatomy of the conduction system anatomy, highlight key pre-procedural planning considerations, and share proven…
View more
Added:
7 months ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus…
View more
Balloon Techniques for Coronary Calcification Lesions
Added:
1 year ago
Review Article
Added:
1 day ago
EuroPCR 2026 – Prof Bruno Scheller (Saarland University Hospital, Homburg, DE) joins us to explore the evolving role of drug-coated balloons in coronary intervention, discussing the latest trial evidence and how it is shaping clinical practice.Interview Questions:How has the role of DCBs in coronary intervention evolved over recent years?What does the latest trial evidence add to our…
View more
Added:
5 days ago
Has the Pressure Wire Had its Day?
Added:
1 year ago
Point-Counterpoint
Drug-coated Balloon Angioplasty in Sri Lanka
Added:
6 months ago
Original Research
Added:
7 months ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible…
View more
Coronary Reactivity Testing for Non‑Obstructive CAD
Video Series
Added:
2 months ago
Source:
Interventional Cardiology Review Journal
For patients with atrial fibrillation (AF) at high risk for both stroke and bleeding, catheter-based left atrial appendage closure (LAAC) was not found to be non-inferior to physician-directed best medical care, according to the results of the CLOSURE-AF trial.¹MethodologyThe multicentre, randomised CLOSURE-AF trial was conducted in Germany to assess the effectiveness of LAAC compared with best…
View more